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R-loops are by-products of transcription that must be tightly regulated to maintain genomic
stability and gene expression. Here, we describe a mechanism for the regulation of the R-
loop-specific helicase, senataxin (SETX), and identify the ubiquitin specific peptidase 11
(USP11) as an R-loop regulator. USP11 de-ubiquitinates SETX and its depletion increases SETX
K48-ubiquitination and protein turnover. Loss of USP11 decreases SETX steady-state levels
and reduces R-loop dissolution. Ageing of USP11 knockout cells restores SETX levels via
compensatory transcriptional downregulation of the E3 ubiquitin ligase, KEAP1. Loss of USP11
reduces SETX enrichment at KEAP1 promoter, leading to R-loop accumulation, enrichment of
the endonuclease XPF and formation of double-strand breaks. Overexpression of KEAP1
increases SETX K48-ubiquitination, promotes its degradation and R-loop accumulation.
These data define a ubiquitination-dependent mechanism for SETX regulation, which is
controlled by the opposing activities of USP11 and KEAP1 with broad applications for cancer
and neurological disease.
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DNA:RNA hybrids (R-loops) are natural byproducts oftranscription. Structural studies suggest a ‘thread backmodel’ of R-loop formation, whereby a nascent RNA
invades the DNA duplex and anneals to the template DNA
strand, causing the non-template DNA strand to be left un-
annealed1. R-loop formation is promoted over G-rich regions and
at sites of RNA polymerase stalling2,3. R-loops occupy ~5% of
human and mouse genomes, and are usually found over promoter
and termination regions4. As R-loops are more thermo-
dynamically stable than double-stranded DNA, they persist until
enzymatically resolved5. There are positive and negative con-
sequences of R-loops. For example, R-loops facilitate class switch
recombination, transcription-associated homologous recombina-
tion and transcription termination6–8, regulate gene expression9
and DNA methylation10. On the other hand, aberrant accumu-
lation of R-loops causes genome instability11–17. Thus, a tight
control of R-loop homeostasis is essential to promote their ben-
eficial effects and avoid their deleterious consequences.
Human cells possess R-loop-specific nucleases such as RNase
H1, RNase H2 and R-loop-specific helicases, such as DHX9,
DDX19, DDX21 and senataxin (SETX)18–20. RNA-binding pro-
teins were also shown to prevent R-loop formation11,21. In
human mitochondria, mtEXO degradosome, which contains a
ribonuclease and a helicase, controls R-loop levels22. SETX was
shown to resolve R-loops at transcription termination sites of
RNA Polymerase II (RNAPII)8 and more recently at sites of
double-strand breaks23. The importance of SETX function is
highlighted by non-sense loss-of-function mutations of SETX,
which cause ataxia with oculomotor apraxia type 2, and missense
gain-of-function mutations, which cause a juvenile form of
amyotrophic lateral sclerosis type 4 (ALS4)24,25. The ALS4
SETXL389S variant was shown to resolve R-loops at 1200 human
promoters leading to transcriptional misregulation26. Further-
more, we recently reported a role for SETX in cancer, by pro-
tecting cells from R-loop-mediated DNA damage in hypoxia,
which is a major cause of resistance to anti-cancer therapeutics27.
Although much is known about R-loop metabolizing enzymes,
little is known about the mechanisms that regulate their home-
ostasis. Protein homeostasis is controlled by many processes such
as ubiquitination and deubiquitination. Ubiquitination is a pro-
cess of conjugating small ubiquitin peptides (8.5 kDa) to lysine
residues of target proteins. As ubiquitin itself possesses lysine
residues, ubiquitin chains and branches can be formed by E3
ligases and trimmed by deubiquitinases (DUBs). Ubiquitination
has been shown to signal for proteasomal degradation, influence
subcellular localization and alter protein–protein interactions or
enzymatic activities28. DUBs have been shown to promote DNA
damage signalling and repair mechanisms. For example, USP1
has been suggested to inhibit translesion synthesis29. USP47
regulates the steady-state levels of DNA polymerase-β, which is
essential for base excision repair30. USP3 and USP16 control cell
cycle progression via deubiquitination of histone 2A (H2A)31,32.
UCHL3 fine tunes topoisomerase-linked DNA break repair via
deubiquitination of TDP133,34. The activity of p53 is also regu-
lated by DUBs35, which further highlights the role of deubiqui-
tination in the maintenance of genome integrity.
Here we conducted an unbiased genetic screen coupled with
cellular and biochemical analyses to reveal the ubiquitin-specific
peptidase 11 (USP11) as an R-loop regulator via controlling SETX
proteostasis. USP11-deficient cells exhibit high levels of R-loops,
which are reduced by expression of wild-type but not catalytically
inactive USP11. Depletion of USP11 or SETX alone increases
detectable R-loops and causes hypersensitivity to topoisomerase I
poisons, and depletion of both does not exacerbate the R-loop
and hypersensitivity phenotypes, indicating that USP11 and
SETX are in the same pathway. Consistent with this, SETX
interacts with USP11 and the interaction is increased by R-loop
induction in a transcription-dependent manner. Depletion of
USP11 increases SETX K48-ubiquitination and degradation,
which leads to accumulation of R-loops that are converted to
double-strand breaks. Finally, we describe a mechanism of cel-
lular adaptation to USP11 loss through transcriptional down-
regulation of the E3 ligase, KEAP1, which counteracts USP11 to
maintain SETX protein levels.
Results
Proteasomal inhibition perturbs R-loop homeostasis. R-loop
homeostasis is controlled by helicases and ribonucleases; how-
ever, little is known about how R-loop-metabolizing enzymes are
regulated. To examine this, we first set out to validate the spe-
cificity of the widely employed R-loop detection method using
S9.6 antibodies in MRC-5 cells. Cells were incubated with the
topoisomerase inhibitor camptothecin (CPT) for 10 min and
S9.6 signal was examined by immunofluorescence (Fig. 1a). The
co-localization of S9.6 with α-nucleolin suggests nucleolar
enrichment of R-loops (Fig. 1a), as CPT treatment did not change
the number of nucleolin foci (Supplementary Fig. 1a). The
number and intensity of nucleolar S9.6 foci increased after 10 min
CPT treatment (Fig. 1b), which is consistent with previous
findings3,36. By masking the nucleolar S9.6 foci, we observed
~40% increase in nuclear S9.6 signal intensity (Fig. 1b). The CPT-
dependent increase of S9.6 signal was specific to R-loops, as it was
ablated by pre-treatment with the R-loop nuclease Escherichia coli
RNase-H (ec-RH) (Fig. 1c). Furthermore, depletion of the R-loop
helicase, SETX, increased nucleolar S9.6 signal, which was also
reversed by ec-RH treatment (Fig. 1d).
To test whether perturbed protein degradation impacts R-loop
homeostasis, MRC-5 and HEK-293 cells were treated with the
proteasomal inhibitor MG132 and examined for R-loop levels.
MG132 treatment increased the nucleolar S9.6 foci measured by
immunofluorescence (Fig. 1e) and by DNA/RNA immunopreci-
pitation (DRIP) followed by quantitative PCR (qPCR) (Fig. 1f and
Supplementary Fig. 1b). We noted that DRIP uncovered an
MG132-dependent increase in R-loops at both RNAPI and
RNAPII loci such as 28S and ING3, respectively. These data
suggest that physiological levels of proteasomal degradation are
required for R-loop homeostasis.
DUB siRNA screen identifies USP11 as a novel R-loop regulator.
We next reasoned that an unbalanced ubiquitin regulation could
perturb R-loop homeostasis. The covalently conjugated ubiquitin is
reversed by DUBs37. If a DUB facilitates deubiquitination of a
protein that is involved in R-loop regulation, then a knockdown of
this DUB should lead to proteasomal degradation of the target
protein and subsequently alter R-loop levels. To test this, we carried
out a high-throughput DUB screen using S9.6 immunostaining as a
readout. We individually depleted 99 human DUBs in MRC-5 cells
using small interfering RNA (siRNA) pools in two different con-
ditions: unchallenged and CPT-treated (Fig. 1g). The S9.6 immu-
nostaining signal was quantified using MetaXpress® software and
the screen was repeated three times. The primary screen uncovered
nine candidates whose knockdown led to either an increase or
decrease in R-loops. The raw data are deposited in Supplementary
Data 1. Depletion of eight of the identified DUBs triggered an
aberrant R-loop levels in either untreated or CPT-treated cells. The
depletion of only one DUB (USP11) consistently caused R-loop
accumulation in both tested conditions (untreated and CPT,
Fig. 1h), suggesting that USP11 is likely a major regulator of
R-loops dissolution.
Deconvolution of the siRNA pool used to knock down each
candidate followed by depletion of USP11 and subsequent R-loop
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accumulation was validated using four siRNA sequences
separately and together (Fig. 2a). The increase in nucleolar
S9.6 signal upon USP11 depletion was specific to R-loops, as it
disappeared in cells ectopically expressing green fluorescent
protein (GFP)-RNase H1 (Fig. 2b). Further, this increase was not
specific to MRC-5 cells, as it was also observed in U2-OS cells
(Supplementary Fig. 1c). Notably, depletion of USP11 led to an
increase in detectable R-loops in both the nucleolar (28S, R7) and
nuclear (ING3, Actin) loci, as measured by DRIP (Fig. 2c and
Supplementary Fig. 1d). We note that under our experimental
conditions, S9.6 immunofluorescence did not reveal a statistically
significant increase of nuclear R-loop signal upon transient
USP11 depletion, which is likely due to the semi-quantitative
nature of the immunostaining and imaging as compared to
quantitative DRIP-qPCR. We therefore validated nucleolar and
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repeating the experiments using recently published DRIP-qPCR
protocols38, employing seven well-characterized primer pairs
including two negative controls (SNRPN-neg and MYADM-neg)
(Supplementary Fig. 1e, f). Together, these data suggest that
USP11 regulates R-loop homeostasis at nucleolar and nuclear
loci.
The catalytic activity of USP11 is required to suppress per-
turbed R-loop levels. Next, we examined whether a persistent
knockout of USP11 also perturbs R-loop levels. To test this, we
generated two USP11-knockout HEK-293 cell lines using CRISPR-
Cas9. USP11-sgRNA clone 1 had a 23nt deletion and USP11-
sgRNA clone-2 had a 2nt deletion, both in exon 1 of the USP11
gene (Supplementary Fig. 2a). As predicted from the sequence, both
clones had no detectable levels of USP11 (Fig. 2d). We then com-
plemented USP11-sgRNA clones 1 and 2 with wild-type USP11 or a
catalytically inactive USP11C318S mutant39–42 (Fig. 2d). In agree-
ment with transient depletion using siRNA, deletion of USP11 led
to elevated nucleolar R-loops as measured by S9.6 immuno-
fluorescence (Fig. 2e, f). Complementation with wild-type USP11,
but not the catalytically inactive USP11C318S mutant, reversed the
perturbed accumulation of R-loops. This observation suggests an
enzymatic role of USP11 to regulate R-loops. We noted that S9.6
immunostaining did not measure a detectable difference between
control and USP11-knockout cells in the nucleoplasm (Supple-
mentary Fig. 2b). However, deletion of USP11 led to increased
R-loops at both nucleolar and nuclear loci when measured by DRIP
(Fig. 2g and Supplementary Fig. 2c). The increase was specific to
USP11 enzymatic activity, as complementation with wild-type
USP11, but not USP11C318S, reduced R-loop levels. This was further
confirmed by a third orthogonal method using slot blot (Supple-
mentary Fig. 2d, e). We conclude from these experiments that the
catalytic activity of USP11 is required for the maintenance of
physiological ‘steady-state’ levels of R-loops.
As loss of USP11 has been linked to genome instability39,41,43,
we reasoned that a proportion of DNA damage observed in
USP11-deficient cells could be due to aberrant accumulation of
R-loops. To test this, we performed an alkaline comet assay to
measure chromosomal breaks in USP11-deficient cells with and
without ectopic expression of GFP-RNase-H1. USP11-deficient
cells possessed higher levels of DNA breaks than control cells,
which were reduced by RNase H1 overexpression (Fig. 2h).
Furthermore, depletion of USP11 led to hypersensitivity to CPT
and Olaparib, which is consistent with previous reports41, and the
hypersensitivity was rescued by overexpression of RNase H1
(Fig. 2i). Together, we conclude from these experiments that
USP11 maintains genome integrity by regulating R-loop levels.
USP11 and SETX act in the same pathway to regulate R-loop
homeostasis. We next set out to address how USP11 regulates R-
loops, primarily guided by its effects on nucleolar R-loops. The
N-terminal domain of SETX1–667 has been shown to localize to
the nucleoli in two independent studies44,45. SETX has also been
reported in a complex with nucleolin, a key component of
nucleoli46. Moreover, SETX1–650 has been suggested to be ubi-
quitinated as shown by a band shift following treatment with
N-Ethylmaleimide (NEM), a cysteine protease that inhibits most
DUBs including USP1147. Our immunostaining is consistent with
the above reports, showing nucleolar localization of SETX1–667
(Supplementary Fig. 3a). Further, USP11 immunostaining
showed both nuclear and nucleolar localization (Supplementary
Fig. 3b). To test whether USP11 and SETX are epistatic, USP11
and SETX were depleted separately and together (Supplementary
Fig. 3c). Interestingly, depletion of USP11 alone led to a mild,
albeit significant, reduction of SETX protein levels, suggesting
that USP11 might control SETX proteostasis. This effect was
specific to SETX, because it did not impact the protein level of
another enzyme involved in protein-linked DNA repair, TDP1
(Supplementary Fig. 3c). Depletion of SETX, USP11 alone or
their co-depletion led to a similar accumulation of R-loops
(Fig. 3a). Furthermore, co-depletion of USP11 and SETX led to
the same hypersensitivity to R-loop-inducing agents such as CPT
and formaldehyde (Fig. 3b and Supplementary Fig. 3d). To
examine whether endogenous USP11 and SETX interact, we
performed proximity ligation assays (PLAs). Under unperturbed
conditions, we detected a PLA signal between USP11 and SETX,
indicating their cellular proximity (Fig. 3c). The PLA signal was
specific, as it was not detected when one of the antibodies was
omitted (Supplementary Fig. 3e). Notably, inducing R-loops by
CPT treatment led to ~5-fold increase in PLA signal. Further-
more, the interaction was transcription dependent, because pre-
treatment with the transcription inhibitor, α-amanitin (AMN),
suppressed the PLA signal (Fig. 3c). We next characterized the
interaction between USP11 and SETX. The residues reported to
mediate USP11 binding to its substrates48 were also required for
binding to SETX, as shown by the lack of PLA signal between
endogenous SETX and the USP11-binding site mutant, GFP-
USP11L208F,S242R (Supplementary Fig. 4a). Consistently,
Fig. 1 A genetic screen uncovers USP11 as a novel R-loop regulator. aMRC-5 cells were treated with DMSO or 25 µM camptothecin (CPT) for 10min and
immediately harvested for S9.6/nucleolin immunofluorescence. Representative confocal images from three biological repeats are shown, scale bar= 3 µm.
bMRC-5 cells were treated with DMSO (Mock; M) or 25 µM CPT (10) for 10min and immediately collected for S9.6/nucleolin immunofluorescence. Data
are the average ± SD from 3 biological repeats, each containing at least 100 cells. The average number of S9.6 foci/cell was calculated (left panel). The
total nucleolar (middle panel) and nuclear (right panel) S9.6 fluorescence was measured using ImageJ and normalized to mock. ns; p > 0.05, two-tailed
Student’s t-test. c MRC-5 cells were treated with DMSO (Mock; M) or 25 µM CPT (10) and then incubated with RNase-H (ec-RH). Cells were then
processed for S9.6/nucleolin immunostaining. Data are the average ± SD from 3 biological repeats, each containing at least 100 cells. The average number
of S9.6 foci/cell was calculated (left panel) and total nucleolar S9.6 fluorescence was measured and normalized to mock (right panel). ns; p > 0.05, two-
tailed Student’s t-test. d MRC-5 cells were transfected with SETX or scrambled (Con) siRNAs and incubated with RNase-H (ec-RH). Cells were processed
for S9.6 immunostaining. The average number of S9.6 foci/cell was calculated and data represent average ± SD from three biological repeats, each
containing at least 100 cells. Two-tailed Student’s t-test. Insert, western blotting showing SETX protein expression with Actin as a loading control. eMRC-5
cells were incubated with DMSO (Mock; M) or 25 µM MG132 (proteasomal inhibitor, PI) followed by S9.6/nucleolin immunostaining. Data are the
average ± SD from 3 biological repeats, each containing at least 100 cells. The average number of S9.6 foci/cell was calculated (left panel) and total
nucleolar S9.6 fluorescence normalized to mock (right panel). *p < 0.05, two-tailed Student’s t-test. f HEK-293 cells were mock incubated with DMSO or
25 µM MG132 (PI) followed by DNA/RNA immunoprecipitation (DRIP) using S9.6 antibodies. Quantitative PCR was conducted using primers targeting
nucleolar (28 S) and nuclear (ING3) loci. The data represent the average ± SD from four biological repeats. Raw % input values are shown in Supplementary
Fig. 1b. Two-tailed Student’s t-test. g Flowchart depicting the design of S9.6 genetic screen. A secondary S9.6 screen was conducted in a 24-well format,
which uncovered USP11 as a new R-loop regulator. h The DUB siRNA screen was performed as described above and data from selected DUBs are presented
showing average S9.6 foci/cell normalized to scrambled siRNA controls from three biological repeats ± SD. ns; p > 0.05, two-tailed Student’s t-test.
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overexpression of wild-type USP11, but not USP11L208F,S242R, in
USP11-knockout cells reduced R-loop levels (Supplementary
Fig. 4b). Finally, both USP11 and SETX were enriched in cells
released to S phase following double-thymidine block (Fig. 3d, e),
which is consistent with Saccharomyces cerevisiae data showing
the SETX orthologue Sen1p is cell cycle-regulated49 and human
data showing the same for USP1141. This provides evidence for a
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cells. Together, these data show that USP11 and SETX interact
physically and functionally to regulate R-loops in a cell cycle-
dependent manner and suggest that SETX might be a substrate
for USP11 DUB activity.
USP11 controls SETX proteostasis. The N-terminal domain of
SETX1–650 has been shown to be ubiquitinated in human cells47,
yet the DUB and the E3 ligase remain unknown. The S. cerevisiae
orthologue of SETX, Sen1p, has also been shown to be
ubiquitinated49. We reasoned that depletion of USP11 could
promote SETX ubiquitination, which would then trigger its
degradation, potentially explaining the elevated R-loop pheno-
type. In line with this hypothesis, both USP11-sgRNA clones
displayed reduced SETX protein levels compared to controls
(Fig. 3f). Complementation of USP11-sgRNA clones with wild-
type USP11 increased endogenous SETX protein levels, whereas
complementation was not possible with the catalytically inactive
USP11C318S (Fig. 3g and Supplementary Fig. 4c). This effect was
likely specific to SETX, because it did not impact the protein level
of another enzyme involved in protein-linked DNA repair,
spartan. The impact of the loss of USP11 on SETX protein levels
was not due to changes in SETX mRNA levels, as shown by
reverse-transcription qPCR (RT-qPCR, Fig. 3h). Furthermore, the
protein turnover of SETX, but not TDP1 as control, was faster in
USP11 sgRNA-knockout cells pre-incubated with the protein
synthesis inhibitor, cycloheximide (CHX), compared to controls
(Fig. 3i, j). Together, these data show that SETX proteostasis is
regulated by USP11 and substantiate the proposition that SETX is
a substrate for USP11 DUB activity.
USP11 depletion increases SETX ubiquitination. To test whe-
ther USP11 regulates SETX by controlling its ubiquitination, we
examined the ubiquitination level of GFP-SETX1–667, full-length
FLAG-SETX and endogenous full-length SETX in control and
USP11-depleted cells using pull-down assays under denaturing
conditions. Higher levels of ubiquitinated SETX1–667, ubiquiti-
nated full-length FLAG-SETX and ubiquitinated endogenous full-
length SETX following normalization to His-ubiquitin were
observed in USP11-depleted cells, as compared to controls
(Fig. 4a, b and Supplementary Fig. 4d, e). This was further con-
firmed by incubating purified ubiquitinated GFP-SETX1–667 with
recombinant USP11. During the in vitro deubiquitination reac-
tion, recombinant USP11 liberated SETX1–667 from the
SETX1–667/ubiquitin-His-nickel beads, resulting in a reduction of
the remaining bead-bound ubiquitinated SETX1–667 (Fig. 4c, d).
These data provide evidence that USP11 depletion leads to
accumulation of ubiquitinated species of SETX1–667, as both
pulldowns were conducted under denaturing conditions. Fur-
thermore, USP11knockout sgRNA Cl-2 cells complemented with
wild-type USP11-possessed lower levels of ubiquitinated GFP-
SETX1–667 compared to cells expressing the catalytically inactive
USP11C318S (Fig. 4e, f). We next attempted to determine the
ubiquitin linkage on SETX by assessing K48-ubiquitination using
denaturing pulldowns. The more GFP-SETX1–667 pulled down,
the more K48-ubiquitination was observed (Fig. 4g). We did not
observe K48 signal in the empty vector-GFP negative control,
suggesting that GFP-SETX1–667 was modified with K48-ubiquitin
chains (Fig. 4g). Next, we compared the K48-ubiquitination level
of GFP-SETX1–667 in control and USP11-deficient cells under
denaturing conditions (Fig. 4h). Higher levels of K48-
ubiquitinated GFP-SETX1–667 following normalization to the
bait (GFP-SETX1–667) were observed in USP11-depleted cells
compared to controls (Fig. 4i), indicating that K48-ubiquitinated
SETX is a substrate for USP11. Finally, and consistent with a role
for SETX during transcription, we observed that GFP-SETX1–667
interacts with endogenous USP11, RNAPII and the largest sub-
unit of RNAPI (RPA-194) (Fig. 4j). A SETX/RNAPI interaction
in human cells is consistent with data from S. cerevisiae showing
interaction of the SETX homologue, Sen1p, with yeast RNAPI50.
Aged USP11-knockout cells restore SETX and R-loop levels. To
gain further insight on the consequences of persistent loss of USP11,
we monitored R-loops in USP11-sgRNA-knockout cells over 12
passages. USP11-sgRNA clones restored R-loops to levels compar-
able to control cells in a passage-dependent manner, as measured by
S9.6 immunostaining (Fig. 5a and Supplementary Fig. 5a) and by
DRIP (Fig. 5b and Supplementary Fig. 5b). The continued passage
also led to restoration of SETX protein levels (Fig. 5c) and increased
Fig. 2 Loss of USP11 triggers R-loop accumulation and R-loop-dependent DNA damage. a MRC-5 cells were transfected with scrambled siRNA (Con),
four different siRNA sequences targeting different regions in USP11 (si1–si4) or pooled siRNA containing all four siRNAs (si1–4). Depletion of USP11 was
examined by immunoblotting (left panel) and by immunofluorescence (right panel). The average number ± SD of S9.6 foci per cell was calculated from 3
biological repeats each containing at least 100 cells. b MRC-5 cells were transfected with USP11 or scrambled 50 nM siRNA (Con) and with human RNase
H1 (hs-RH1). Cells were then processed for S9.6/nucleolin immunostaining. Data are the average ± SD from 3 biological repeats, each containing at least
100 cells and presented as the average number of S9.6 foci/cell (left panel) and mean S9.6 nucleolar intensity (right panel). p-Values calculated using two-
tailed Student’s t-test. c Lysates from Control (Con siRNA) and USP11-depleted cells (USP11 siRNA) were subjected to DNA/RNA immunoprecipitation
(DRIP) using S9.6 antibodies. Quantitative PCR was conducted using primers targeting nucleolar (28S and R7) and nuclear (ING3 and actin) loci. The data
represent the average ± SD from three biological repeats. Raw % input values are shown in Supplementary Fig. 1d. p-Values calculated using two-tailed
Student’s t-test. d HEK-293 cells were transfected with a vector expressing Cas9 and sgRNA targeting exon 1 of USP11. USP11-knockout clones were then
stably complemented by vectors encoding full-length FLAG-HA-USP11 (WT) or catalytically inactive FLAG-HA-USP11C318S mutant (C318S). The images are
representative of three biological repeats. e, f USP11 sgRNA clones (Cl-1 and Cl-2) and those complemented with WT USP11 or the C318S mutant were
examined by S9.6/nucleolin immunofluorescence. The average number of S9.6 foci/cell (e) and total nucleolar fluorescence normalized to control (Cont)
cells (f) were calculated from 3 biological repeats, each containing at least 100 cells and presented as average ± SD. p-Values calculated using two-tailed
Student’s t-test. g Lysates from Control (Cont) and USP11 sgRNA Cl-2 and USP11 sgRNA Cl-2 complemented with USP11 (WT) or catalytically inactive
USP11C318S mutant (C318S) were subjected to DNA/RNA immunoprecipitation using S9.6 antibodies. Quantitative PCR was conducted using primers
targeting nucleolar (28S and R7) and nuclear (ING3 and actin) loci. The data represent the average ± SD from three biological repeats. Raw % input values
are shown in Supplementary Fig. 2c. p-Values calculated using two-tailed Student’s t-test. h Control (Con si) and USP11-depleted MRC-5 cells (USP11si)
were transfected with plasmids encoding eGFP-EV (EV) or eGFP-RNase H1 (RH1). The expression level of USP11, eGFP-Rnase H1 and Tubulin was analysed
by immunoblotting. * denotes a nonspecific band (left panel). Chromosomal breaks were quantified by an alkaline comet assay and data represent the
average of 3 biological replicates ± SD, each containing 125 cells (right panel). p-Values calculated using two-tailed Student’s t-test. i MRC-5 cells
transfected with Control (control) or USP11 siRNA and eGFP-EV (EV) or eGFP-RNase H1 (RH1) were incubated with the indicated doses of Olaparib or CPT
and left to grow for 7 days. The surviving colonies were counted and % survival calculated relative to mock-treated cells. Data are the average ± SEM from
three biological repeats. p-Values calculated using two-tailed Student’s t-test.
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expression of the ageing senescence marker, p21 (Supplementary
Fig. 5c). These findings were not due to restoration of USP11 levels,
which remained undetectable in late passages (Fig. 5c). Furthermore,
they were not due to age-related changes in SETX mRNA levels,
which remained similar throughout the lifespan of both USP11-
sgRNA clones (Fig. 5d). We therefore reasoned that the restoration
of SETX protein levels was an adaptation to the continued loss of
USP11 via changes in SETX post-translational control rather than
altered transcription rates. USP11 has been shown to promote the
formation of BRCA1-PALB2-BRCA2 complex, which is opposed by
the E3 ubiquitin ligase, KEAP141. Interestingly, KEAP1 mRNA and
protein levels were downregulated in the aged USP11-sgRNA clones
(passage ≥ 12) when compared to early passages (Fig. 5e, f). Fur-
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reduced SETX protein levels (Fig. 5g). We next examined whether
endogenous KEAP1 interacts with SETX. Under unperturbed con-
ditions, we observed a positive PLA signal, which was significantly
increased following R-loop induction by CPT (Fig. 5h). The inter-
action between KEAP1 and SETX was transcription-dependent as
the PLA signal was reduced by pre-incubation with the transcription
inhibitor, AMN (Fig. 5h). Together, we conclude that SETX might
be a substrate for KEAP1 E3 ubiquitin ligase activity.
KEAP1 opposes USP11 to control SETX protein levels. We next
examined whether KEAP1 regulates SETX proteostasis by con-
trolling its ubiquitination. Overexpression of KEAP1 led to an
increased ubiquitination GFP-SETX1–667, full-length FLAG-
SETX and endogenous full-length SETX (Fig. 6a and Supple-
mentary Fig. 5d, e). This was specific to KEAP1 as overexpression
of the catalytic subunit of another E3 ubiquitin ligase,
RNF1681–110, did not increase SETX ubiquitination (Supple-
mentary Fig. 5e). To test whether USP11 and KEAP1 act in an
opposing manner to regulate SETX ubiquitination, we depleted
USP11 and KEAP1 separately and together (Supplementary
Fig. 5f), and examined SETX ubiquitination using denaturing
pulldowns. Depletion of KEAP1 was sufficient to reduce the
increased levels of SETX ubiquitination in USP11-deficient cells
(Fig. 6b), suggesting that KEAP1 and USP11 antagonistically
regulate SETX ubiquitination. Consistently, depletion of KEAP1
reduced the increased levels of R-loops in USP11-deficient cells
(Fig. 6c). Furthermore, overexpression of KEAP1 increased the
levels of K48-ubiquitinated SETX, as measured by denaturing
pulldowns (Fig. 6d). These data are consistent with the reduced
SETX protein levels following KEAP1 overexpression (Fig. 5g)
and the increased SETX K48-ubiquitination following USP11
depletion (Fig. 4h). Together, we conclude that KEAP1 opposes
USP11 to regulate SETX ubiquitination and proteostasis.
Loss of USP11 reduces SETX binding to KEAP1 promoter and
increases R-loops. We next wondered why loss of USP11 reduces
KEAP1 transcript and protein levels. First, we examined USP11
binding to established R-loop loci using chromatin immunopre-
cipitation (ChIP). USP11 was bound to R-loop-positive loci such
as 28S, R7, ING3, Actin, EGR1 and R-loop-negative loci such as
MYADM-neg, SNRPN-neg (Supplementary Fig. 6a), which is
consistent with the broad roles of USP11 on chromatin43,51.
However, USP11 occupancy at R-loop-positive loci, but not R-
loop-negative loci, was reduced following SETX depletion
(Fig. 7a). This observation suggests that SETX promotes enrich-
ment of USP11 at R-loops. Of note is the observed USP11 binding
to KEAP1 promoter, which is also reduced upon SETX depletion
(Fig. 7a). To test whether SETX increases USP11 binding to
chromatin globally, we performed nuclear fractionation assays.
Depletion of SETX did not reduce USP11 levels in the insoluble
chromatin fraction (Supplementary Fig. 6b), suggesting that
SETX regulates USP11 chromatin enrichment at specific genomic
sites and not globally. Next, we examined whether SETX binds to
the same loci. As expected, SETX was enriched at R-loop-positive,
but not -negative, loci (Supplementary Fig. 6c). Notably, we also
observed a significant enrichment of SETX at the KEAP1 pro-
moter. Next, we examined whether enrichment of SETX on
chromatin is USP11-dependent. Loss of USP11 reduced SETX
binding to promoters (KEAP1, EGR1) and gene bodies (ING3)
but not 3′ gene ends (28S, R7, Actin) (Fig. 7b and Supplementary
Fig. 6d). The reduced SETX binding at KEAP1 promoter in
USP11-deficient cells suggest that perturbations in R-loops in this
region may explain the reduced KEAP1 transcripts upon USP11
loss. Consistently, loss of USP11 increased R-loop levels at the
KEAP1 promoter (Fig. 7c). Together, we conclude that loss of
USP11 not only increases SETX K48-ubiquitination and protein
turnover but also reduces the binding of the remaining pool of
SETX to R-loop loci including the KEAP1 promoter, leading to
R-loop accumulation.
R-loops formed following USP11 deficiency are converted to
double-strand breaks. We next examined whether the increased
R-loops upon USP11 loss are converted to double-strand breaks.
To test this, we performed γH2AX ChIP-qPCR using the same
primers used for DRIP (Fig. 7d). Loss of USP11 increased γH2AX
Fig. 3 USP11 and SETX work together to regulate R-loop homeostasis. a MRC-5 cells treated with control (Con), USP11, SETX or USP11 and SETX siRNA
were analysed by S9.6/nucleolin immunostaining. Data are the average ± SD from 3 biological repeats, each containing at least 100 cells and presented as
average number of S9.6 foci/cell (left panel) and mean S9.6 nucleolar intensity (right panel). p-Values calculated using two-tailed Student’s t-test. b MRC-
5 cells treated with control (Con), USP11, SETX or USP11 and SETX siRNA were incubated with the indicated doses of CPT for 1 h and left to grow for 7 days.
The surviving colonies were counted and % survival calculated relative to mock-treated cells. Data are the mean ± SD from three biological repeats. p-
Values calculated using two-tailed Student’s t-test. c MRC-5 cells mock treated with DMSO (DMSO), 25 µM CPT for 10 min or α-amanitin (AMN)
overnight followed by CPT were subjected to proximity ligation assay using antibodies against endogenous USP11 and SETX. Representative images are
shown, scale bar is equal to 10 µm (left panel). The signal intensity was measured using ImageJ (right panel). Data are the mean ± SD from three biological
repeats. p-Values calculated using two-tailed Student’s t-test. d HEK-293 cells were synchronized to G1/S boundary (G1/S) by a double-thymidine block.
Asynchronized (AS) cells served as a control. The expression level of SETX, USP11, cyclin A2 and tubulin was analysed by immunoblotting. * denotes a
nonspecific band. The images are representative of three biological repeats. e The band intensity of SETX and USP11 was quantified from five biological
repeats of d, normalized to tubulin and then presented as fold increase of the mean ± SD compared to asynchronized samples. p-Values calculated using
two-tailed Student’s t-test. f Lysates from Control (Cont) and USP11-knockout HEK-293 cells (sgRNA Cl-1 and Cl-2) were fractionated by SDS-PAGE and
analysed by immunoblotting using SETX, USP11 and GAPDH antibodies (top panel). SETX band intensities were normalized to GAPDH and presented as
fold reduction compared to levels in control parental cells (bottom panel). Data are the average of five biological repeats and presented as mean ± SD. p-
Values calculated using two-tailed Student’s t-test two-tailed Student’s t-test. g Lysates from USP11 sgRNA Cl-1 and Cl-2 complemented with wild-type
USP11 (WT) or catalytically inactive USP11C318S mutant (C318S) were fractionated by SDS-PAGE and analysed by immunoblotting using SETX, USP11,
SPRTN and actin antibodies (left panel). SETX band intensities were normalized to actin and presented as fold increase as compared to C318S cells (right
panel). Data are the average of five biological repeats and presented as mean ± SD. p-Values calculated using two-tailed Student’s t-test. h Total RNA was
extracted from USP11-knockout clones at passage 2–7 (sgRNA Cl-1 and 2) and control cells (Cont), reverse transcribed to cDNA, and USP11 and SETX
transcripts were quantified by qPCR. Data are the mean of three biological repeats ± SD, normalized to actin transcript levels and presented as % reduction
compared to controls. ns; p > 0.05, two-tailed Student’s t-test. i Parental HEK-293 (Con) and USP11 sgRNA Cl-2 cells were incubated with cycloheximide
(CHX). The expression level of SETX, USP11, TDP1 and Tubulin was analysed by immunoblotting. The images are representative of three biological repeats.
j The band intensity of SETX and TDP1 following incubation with CHX was quantified from three biological repeats, normalized to tubulin and then
presented as fold reduction of the mean ± SD compared to untreated samples; p > 0.05, two-tailed Student’s t-test.
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in both R-loop-positive and -negative loci, which is consistent
with the role of USP11 in homologous recombination39,41.
Importantly, however, the accumulation of γH2AX in USP11-
depleted cells was reduced by RNase H1 only in R-loop-positive,
but not R-loop-negative, loci (Fig. 7d). We therefore reasoned
that the R-loops that accumulate in USP11-deficient cells might
be processed by endonucleases to double-strand breaks. XPF is
a DNA repair structure-specific flap endonuclease that has been
reported to cleave R-loops to double-strand breaks52,53. Depletion
of USP11 increased XPF occupancy at R-loop-positive loci
including the KEAP1 promoter, in an RNase H1-dependent
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R-loops (Fig. 7f), XPF occupancy and γH2AX (Fig. 7g) at two
established common fragile sites (FRA16 and FRA3B)54, which
was again RNase H1-dependent. Taken together, we conclude
that USP11 deficiency increases SETX ubiquitination, reduces
SETX protein levels and binding to R-loops at specific genomic
sites including KEAP1 promoter and common fragile sites, which
leads to formation of R-loop that are converted to double-strand
breaks.
Discussion
We describe a series of experiments defining USP11 as a DUB for
SETX and thus an R-loop regulator. First, using multiple ortho-
gonal methods, we show that loss of USP11 increases nuclear and
nucleolar R-loops in human cells. We then demonstrate that
USP11 and SETX are epistatic in terms of R-loop regulation and
cell survival after treatment with R-loop inducing agents. We
further show cellular physical proximity of endogenous USP11
and SETX, which is increased by R-loop induction in a
transcription-dependent manner. USP11 depletion increased
SETX K48-ubiquitination and SETX protein turnover. These
effects were dependent on USP11 DUB activity as shown by
experiments using a catalytically inactive mutant. The adaptation
of USP11-knockout CRISPR cells and restoration of SETX pro-
tein levels in passage-dependent manner led to the identification
of the role of KEAP1 in SETX regulation.
We provide evidence that KEAP1 interacts and ubiquitinates
SETX with K48-ubiquitin chains, which targets SETX for degra-
dation. We further show by DRIP-qPCR and ChIP-qPCR that
loss of USP11 increases R-loop accumulation at KEAP1 promoter,
which triggers double-strand breaks, providing a plausible
explanation for the culture adaptation and downregulation of
KEAP1 transcription in USP11-deficient cells. The down-
regulation of KEAP1 transcript levels was only observed in aged
USP11-sgRNA clones (Fig. 5e, f), which is consistent with a
model in which passage-dependent accumulation of R-loops
caused by USP11 loss and subsequent SETX degradation triggers
increased DNA damage (Fig. 2h) and accelerated ageing (Sup-
plementary Fig. 5c), and that cells effectively adapt by down-
regulation of KEAP1. This mode of regulation is not unprecedent.
USP11 has been recently shown to positively regulate the stability
of the master regulator of oxidative-stress response, NRF255,
which is also negatively regulated by KEAP156. Loss of USP11
increased ubiquitination of NRF2 and its subsequent degradation,
which led to downregulation of transcription of NRF2-target
genes55. Depletion of NRF2 was also shown to reduce tran-
scription of KEAP1, resulting in low KEAP1 steady-state levels57.
Our data support a model in which KEAP1 and USP11
antagonistically control ubiquitination of SETX to regulate its
protein levels and consequently regulate R-loop homeostasis
(Fig. 7h and Supplementary Fig. 6e). This is reminiscent to pre-
vious findings whereby USP11 and KEAP1 were also reported to
antagonistically control the stability of PALB241 and NRF255,58.
The increased global binding of SETX to both USP11 and KEAP1
following R-loop induction by CPT is intriguing. We suggest the
extent of this binding is adjusted to favour more binding to
USP11, thus increasing SETX levels, or more binding to KEAP1,
thus reducing SETX level, at different genomic loci. This layer of
spatial regulation would ensure a fine balance between physio-
logical R-loops that are required to promote transcription vs.
pathological R-loops, which cause genomic instability. A genome-
wide DRIP and ChIP-sequencing approach will address this idea.
Nevertheless, pharmacological or pathological perturbations of
this balance will have detrimental cellular consequences. For
example, mitoxantrone is a small molecule inhibitor of USP11,
which has been shown to be effective in cancer cells over-
expressing USP1159. Our clonogenic cell survival data show that
USP11-deficient cells are hypersensitive to R-loop-inducing
agents such as CPT. Thus, a combination of CPT and mitoxan-
trone may offer a new targeted approach to treat certain cancers.
Reduction of SETX levels via USP11 inhibition could also over-
come cancer resistance caused by hypoxia27. Furthermore, as
USP11 regulates SETX protein stability, mitoxantrone could be
used to treat disorders where SETX is overexpressed or where its
activity and levels are pathogenic. ALS4 is a neurodegenerative
disorder caused by a gain-of-function SETX mutation47. Mod-
erate, but prolonged, depletion of USP11 could lead to down-
regulation of the mutated SETX, which in turn could alleviate or
delay symptoms of ALS4. Furthermore, disorders characterized
by an excessive R-loop accumulation with no reported link with
USP11-SETX-KEAP1 axis, such as the most common form of
familial ALS that is caused by C9orf72 expansions16,60,61, could
potentially benefit from USP11 activators or KEAP1 inhibitors62.
The majority of chromosomal breaks observed in USP11-deficient
cells were caused by aberrant R-loop accumulation (Fig. 2h) and the
Fig. 4 USP11 regulates SETX ubiquitination. a, b Control (Con si) and USP11-depleted HEK-293 cells (USP11 si) were transfected with Ub-His plasmid,
treated with MG132 overnight (PI), lysed and subjected to nickel pull-down under denaturing conditions to purify ubiquitinated proteins. Samples were
fractionated by SDS-PAGE and analysed by immunoblotting using anti-SETX, USP11 and His antibodies. a The band intensities of Ubi-SETX were
normalized to His-Ub and presented as fold increase of SETX ubiquitination compared to controls (b). Data are the average ± SD from three biological
repeats. p-Values calculated using two-tailed Student’s t-test. c, d Purification of Ubi-eGFP-SETX1–667 was conducted as described above followed by
incubation of the nickel beads with BSA or recombinant USP11 in a deubiquitination buffer. Samples were fractionated by SDS-PAGE and analysed by
immunoblotting using anti-GFP, USP11, His and actin antibodies. * denotes a nonspecific band (c). The band intensities of Ubi-eGFP-SETX1–667 were
normalized to His-Ub and presented as fold increase of SETX ubiquitination compared to controls (d). Data are the average ± SD from three biological
repeats. ns; p > 0.05, two-tailed Student’s t-test. e, f USP11 sgRNA Cl-2 cells expressing wild-type USP11 (WT) or the catalytically inactive USP11C318S
mutant (C318S) were transfected with plasmids encoding eGFP-SETX1–667 and Ub-His; and ubiquitinated eGFP-SETX1–667 was purified using Nickel pull-
down under denaturing conditions. * denotes a nonspecific band (e). The band intensities of Ubi-eGFP-SETX1–667 were normalized to His-Ub and presented
as fold increase of SETX ubiquitination compared to WT (f). Data are the average ± SD from three biological repeats. p-Values calculated using two-tailed
Student’s t-test. g HEK-293 cells expressing an empty vector-eGFP (EV) or eGFP-SETX1–667 were lysed under denaturing conditions and subjected to GFP
pull-down to purify eGFP-SETX1–667. Samples were fractionated by SDS-PAGE and analysed by immunoblotting using anti-GFP and K48 antibodies. The
images are representative of three biological repeats. h, i HEK-293 cells expressing eGFP-SETX1–667 were transfected with control siRNA (Con Si) or
USP11 siRNA (USP11 Si), lysed and subjected to GFP pull-down under denaturing conditions to purify eGFP-SETX1–667. Samples were fractionated by SDS-
PAGE and analysed by immunoblotting using anti-GFP, K48 and USP11 antibodies (h). The intensity of K48 signal was normalized to pulled down eGFP-
SETX1–667 signal and presented as fold increase of SETX K48-ubiquitination in USP11 Si cells compared to controls (i). Data are the average ± SD from three
biological repeats. p-Values calculated using two-tailed Student’s t-test. j HEK-293 cell lysates expressing an empty vector-eGFP (EV-GFP) or eGFP-
SETX1–667 were subjected to GFP pull-down and analysed by immunoblotting using antibodies against GFP, USP11, RNA polymerase II (RNAPII) and RNA
polymerase I (RPA-194).
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reported hypersensitivity of USP11-deficient cells to PARP
inhibitors39,41 was reduced by RNase H1 overexpression (Fig. 2i).
This is consistent with recent reports implicating R-loops in the
cellular response to PARP inhibitors63 and with reports showing
that the hypersensitivity of USP11-deficient cells to the PARP
inhibitor, olaparib, could be overcome by depletion of KEAP141.
Therefore, perturbations in R-loop homeostasis are likely playing a
key role in the evolving resistance to PARP inhibitors.
We further show that USP11 depletion reduces SETX enrich-
ment at KEAP1 promoter and increases R-loop accumulation, the
double-strand break marker γH2AX and the endonuclease XPF,
at the same genomic sites. These observations support a model in
which loss of USP11 not only increases SETX K48-ubiquitination
and reduces SETX protein stability but also reduces the binding of
the remaining SETX pool to the KEAP1 promoter. This leads to
R-loop accumulation, which are then processed by XPF to
double-strand breaks, resulting in adaptation by transcriptional
downregulation of KEAP1. This model is not likely to be
restricted to KEAP1, as it was also true at two common fragile
sites, which is consistent with published findings linking USP11
to genomic instability and carcinogenesis64,65.
Loss of USP11 reduced SETX binding to promoters (KEAP1,
EGR1) and gene bodies (ING3) but not transcription end sites
(28S, R7, Actin) (Fig. 7b). These findings not only provide a
plausible explanation for the culture adaptation by down-
regulation of KEAP1 transcription but are also exciting, because
SETX was previously shown to be recruited by BRCA1 to tran-
scription termination sites to resolve R-loops66; however, how
SETX is recruited to promoter-proximal regions and gene bodies
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putative candidate fulfilling this function by recruiting SETX to
non-transcription end sites. Whether this model is true and to
what extent it is impacted across the lifespan and by ageing
remain to be determined67. We also note that human SETX has
not been shown to be involved in RNAPI termination, unlike its
S. cerevisiae orthologue Sen1p50. Here, we demonstrate that
ectopically expressed SETX1-667 immunoprecipitates with RNAPI
large subunit, RPA-194, suggesting a possible role for SETX in
human RNAPI termination. Further, we show that both USP11
and SETX steady-state levels are increased as cells enter the S
phase, which is consistent with the yeast data whereby Sen1p was
upregulated in S phase and degraded in G1 by the Ubiquitin-
Proteasome System49, and with human data showing enrichment
of R-loops in S phase compared to G168.
Finally, this report provides evidence and mechanistic expla-
nation for how cellular phenotypes obtained by genome editing
are subject to transcriptional adaptation. It opens new avenues of
research that involves comparative investigation of young vs. aged
gene-edited cells and organisms to uncover new genetic
interactions.
In summary, we employed a genetic screen and took advantage
of a cellular adaptation model to define a ubiquitination-
dependent mechanism for R-loop regulation by SETX, which is
controlled by the opposing activities of USP11 and KEAP1 with
broad applications for cancer and neurological disease.
Methods
Cell lines and cell culture. MRC-5, HEK-293 and HEK-293 CRISPR cell lines
were grown as monolayers in minimum essential media (MEM) supplemented
with 10% fetal calf serum (FCS) and 1% L-Glutamine in 5% CO2 incubators at
37 °C. U2-OS cell line was grown in McCoy’s 5A media (modified) supplemented
with 10% FCS in 5% CO2 incubators at 37 °C. All cells were routinely tested
negative for mycoplasma.
Antibodies, siRNAs, primers and plasmids. All information regarding anti-
bodies, siRNAs, primers and plasmids is listed in Supplementary Tables 1–4.
siRNA transfections were carried out at a final 50 nM concentration unless
otherwise stated.
Generation of USP11 KO clones. Small guide RNA against exon 1 of USP11 was
designed—forward 5′-CAC CGA GAA CGG ACG GCG ATG GCG A-3′, reverse
5′-AAA CTC GCC ATC GCC GTC CGT TCT C-3′—and cloned into
pSpCas9n(BB)-2A-GFP. HEK-293 cells were transfected with pSpCas9n(BB)-2A-
USP11 sgRNA-GFP. Serial dilution was used to obtain homogenous colonies,
which were screened by immunoblotting with anti-USP11 antibody. Successful
USP11-knockout (KO) clones were confirmed by DNA sequencing. USP11 sgRNA
clones 1 and 2 were transfected with either wild-type FLAG-HA-USP11 or cata-
lytically inactive FLAG-HA-USP11C318S plasmids and subsequently selected with
puromycin to form stable populations expressing exogenous USP11.
CHX chase experiment. 2.0 × 105 USP11-sgRNA clone-2 or HEK-293 cells were
seeded in six-well plates, (if required) transfected with USP11 siRNA or control
siRNA to a final concentration of 25 nM, left for 48 h and treated with 50 µg/ml
CHX and 5 µM MG132 for 24 h. Next, cells were lysed in 50 mM Tris-HCl pH 8,
40 mM NaCl, 2 mM MgCl2, Triton (0.5% v/v), 1× Protease Inhibitor, 20 mM NEM,
250 units of Basemuncher (Expedeon) and analysed by immunoblotting. SETX
band intensity was first normalized to actin and then presented as fold reduction
compared to untreated samples.
Reverse-transcription qPCR. RNeasy® Mini Kit (Qiagen, Valencia, CA) was used
to purify total RNA from HEK-293 cells. Total RNA was quantified (NanoDrop,
ThermoFisher) and 5 µg were used immediately to synthesize cDNA (High
Capacity RNA-to-cDNA Kit, catalogue number: 4387406, ThermoFisher). Twenty
microlitres of the total reaction volume contained 1× Reverse Transcription Buffer,
4 mM dNTP Mix, 1× Reverse Transcription Random Primers, 1× MultiScribe™
Reverse Transcriptase and 5 µg of total RNA. The thermocycling conditions were
set to 25 °C for 10 min, 37 °C for 120 min and 85 °C for 5 min. cDNA samples were
diluted 1 : 10 in ddH2O. Five microlitres of diluted cDNA was mixed with 1×
SensiMix™ SYBR® & Fluorescein reaction mix (containing 3 mM MgCl2) (Bioline,
UK, catalogue number: QT615-05) and 0.7 nM primer pair in 20 µl total reaction
volume. At this stage, all experimental and reference samples were prepared
manually in duplicates. Thermocycling conditions were set to 95 °C for 10 min,
which was followed by 45 cycles of 95 °C for 15 s, 55 °C for 15 s and 72 °C for 30 s.
Rotor-Gene 6000 series Software 1.7 (Corbett Life Science) was used to determine
the quantification cycle (Cq) value (which is a number at which the fluorescence
signal is significantly above the background noise). Next, Cq values were converted
to copy numbers using standard curve method (four standard dilutions in dupli-
cates). Gene expression was normalized to β-actin mRNA levels. Values in the
control cells were treated as 100%.
DNA/RNA immunoprecipitation. DRIP for all the figures, except Supplementary
Fig. 2c and Figs. 6c and 7c, was essentially performed as ChIP with minor mod-
ifications. For Supplementary Fig. 2c and Figs. 6c and 7c, a more recently published
DRIP-qPCR protocol was followed38. Briefly, HEK-293 cells were lysed in standard
ChIP lysis buffer for 10 min: 50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM
EDTA pH 8, 1% Triton X-100, 0.1% Sodium Deoxycholate and 0.1% SDS. Next,
digests were sonicated for 7 min (30 s on, 30 s off) using Bioruptor Pico (Diag-
enode, Liege, Belgium). The sonicated samples were incubated with 28 µg of S9.6
antibodies for an hour at 4 °C. Meanwhile, Protein A Dynabeads (Thermo Fisher
Scientific, Waltham, MA) were washed three times in standard RIPA buffer and
added to the sonicated digests for overnight precipitation at 4 °C. The next day,
samples were or were not on-bead digested with ec-RH (20 units, NEB, Ipswich,
MA) for 2 h at 37 °C. Then, the beads were washed once with low-salt wash buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 150 mM
Fig. 5 Aged USP11-knockout cells restore SETX and R-loop levels via downregulation of KEAP1. a Parental HEK-293 cells (Cont) and USP11-knockout
clones 1 and 2 (Cl-1 and Cl-2) at passage 1–14 (p12) were examined for R-loop levels using S9.6/nucleolin immunostaining. The average number of S9.6
foci/cell (left panel) and total nucleolar fluorescence normalized to control cells (right panel) were calculated from three biological repeats, each containing
at least 100 cells and presented as average ± SD. ns; p > 0.05, two-tailed Student’s t-test. b Lysates from Control (Cont) and USP11-knockout clone-2 at
passage 12–15 (p12) were subjected to DNA/RNA immunoprecipitation (DRIP) using S9.6 antibodies. Quantitative PCR was conducted using primers
targeting nucleolar (28S and R7) and nuclear (ING3 and actin) loci. The data represent the average ± SD from four biological repeats. Raw % input values
are shown in Supplementary Fig. 5b. ns; p > 0.05, two-tailed Student’s t-test. c Lysates from parental HEK-293 cells (Cont) and USP11-knockout clones 1
and 2 (Cl-1 and Cl-2) at passage 12–14 (p12) were fractionated by SDS-PAGE and analysed by immunoblotting (left panel). SETX band intensities were
normalized to actin and presented as fold increase compared to control cells (right panel). Data are the mean of four biological repeats ± SD. ns; p > 0.05,
two-tailed Student’s t-test. d, e Total RNA was extracted from young (p1–4) and aged (p12–15; p12) USP11 sgRNA clones, reverse transcribed to cDNA and
transcript levels of SETX and KEAP1 were quantified by qPCR. SETX and KEAP1 mRNA levels were first normalized to actin and then presented as % change
compared to levels in control cells. Data are the mean ± SD from three biological repeats. p-Values calculated using two-tailed Student’s t-test. f Lysates
from young (p1–4) and aged (p12–15, p12) USP11 sgRNA clone-2 (Cl-2) were fractionated by SDS-PAGE and analysed by immunoblotting (left panel).
KEAP1 band intensities were normalized to tubulin and presented as fold decrease compared to p1–4 (right panel). Data are the mean of three biological
repeats ± SD. p-Values calculated using two-tailed Student’s t-test. g Lysates from USP11-knockout clone-2 (Cl-2) at passage 12 were transfected with
empty vector (EV) or HA-KEAP1 (HA) plasmids and fractionated by SDS-PAGE for immunoblotting analysis. Two biological repeats are shown (left panel).
SETX band intensities were normalized to actin and presented as fold decrease compared to EV (right panel). Data are the mean of five biological
repeats ± SD. p-Values calculated using two-tailed Student’s t-test. h MRC-5 cells treated with mock (DMSO) or α-amanitin (AMN) overnight followed by
10min incubation with 25 µM CPT were subjected to proximity ligation assay using antibodies against endogenous KEAP1 and SETX. Representative
images are shown, scale bar is equal to 10 µm (left panel). The signal intensity was measured using ImageJ (right panel). Data are the mean ± SD from
three biological repeats. p-Values calculated using two-tailed Student’s t-test.
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NaCl), once with high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-HCl pH 8.0, 300 mM NaCl) and once with Lithium Chloride wash
buffer (0.25 M LiCl, 1% NP-40, 1% Sodium Deoxycholate, 1 mM EDTA, 10 mM
Tris-HCl pH 8.0). Next, R-loops were eluted by adding 150 µL of elution buffer (1%
SDS, 100 mM NaHCO3) to the protein A Dynabeads and vortexed slowly for
15 min at 30 °C. Next, 150 mM NaCl, 150 µg/mL RNase A and 300 µg/mL pro-
teinase K were added and incubated for 1 h at 37 °C. Next, R-loops were purified
using standard phenol–chloroform protocol followed by ethanol precipitation.
R-loops were resuspended in 50 µl RNase/DNase-free water. Two microlitres of the
suspension were used for a qPCR reaction as described above for RT-qPCR. R-loop
accumulation in each gene loci was determined as % input.
Chromatin immunoprecipitation. HEK-293 or USP11 sgRNA-2 HEK-293 cells
were crosslinked for 10 min with 1% formaldehyde, quenched with 125 mM glycine
and lysed in ChIP lysis buffer (1% SDS, 5 mM EDTA, 50 mM Tris-HCl pH 8.1) for
10 min. Next, digests were sonicated for 7 min (7 cycles, 30 s on, 30 s off) using
Bioruptor Pico (Diagenode, Liege, Belgium). One hundred micrograms of soni-
cated samples were diluted 10× in ChIP dilution buffer (1% Triton X-100, 2 mM
EDTA, 150 mM NaCl, 20 mM Tris-HCl pH 8.1) and incubated with an appropriate
antibody overnight. Next day, 25 µl of Protein A or G Dynabeads (Thermo Fisher
Scientific, Waltham, MA) were washed three times in the ChIP dilution buffer and
added to the sonicated digests for 3 h immunoprecipitation at 4 °C. Next, the beads
were washed once with low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl pH 8.0, 150 mM NaCl), once with high-salt wash buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 300 mM
NaCl), once with Lithium Chloride wash buffer (0.25 M LiCl, 1% NP-40, 1%
Sodium Deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.0) and once with 1×
TE buffer. Next, chromatin was eluted by adding 150 µL of elution buffer (1% SDS,
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NaCl was added to 150 mM final concentration and samples were incubated for
24 h at 65 °C. Next, 150 µg/mL RNase A was added for 30 min at 37 °C and 300 µg/
mL proteinase K was added for 2 h at 65 °C. Then, DNA was purified using
standard phenol–chloroform protocol followed by ethanol precipitation. DNA was
resuspended in 50 µl qPCR-quality water. Two microlitres of the suspension were
used for a qPCR reaction as described above for RT-qPCR. Protein accumulation in
each gene loci was determined as % input.
DNA/RNA immunoprecipitation quantitative PCR. DRIP-qPCR was conducted
following a recently published protocol38. siRNA-transfected HEK-293 cells were
grown in 15 cm dishes. They were lysed o/n in 37 °C in TE buffer containing
0.625% SDS and 62.5 µg/ml proteinase K. DNA was extracted following standard
phenol–chloroform and ethanol precipitation methods. Post precipitation, DNA
was spooled using a cut tip and subsequently digested overnight using a restriction
enzyme cocktail (30 units of each: BsrGI, EcoRI, HindIII, SspI and XbaI). Next,
8 µg of digested DNA was incubated with 15 units of RNase-H enzyme for 4–6 h.
Subsequently, 8 µg of digested DNA and 8 µg of RNase-H-treated DNA was
incubated o/n with 20 µl of S9.6 antibody (ENH001, Kerafast) in DRIP binding
buffer (10 mM sodium phosphate pH 7.0, 140 mM NaCl, 0.05% (v/v) Triton X-100,
TE). Next, 100 µl of protein G beads were washed three times in DRIP binding
buffer and added to the tubes from the previous step, and incubated for 2 h in 4 °C.
Subsequently, the beads were washed three times in DRIP binding buffer and then
R-loops were eluted in the elution buffer (50 mM Tris pH 8.0, 10 mM EDTA pH
8.0, 0.5% (v/v), 0.456 mg/ml proteinase K). The elution was carried out in a rotor at
55 °C for 45 min. Next, the eluate was subjected to standard phenol–chloroform
extraction and ethanol precipitation. Obtained DNA was quantified by qPCR as
described above. R-loop accumulation in each gene loci was determined as % input.
Fractionation of nuclear fractions. HEK-293 cells were lysed on ice in hypotonic
buffer (20 mM HEPES pH 8.0, 10 mM KCl, 1 mM MgCl2, 20% glycerol, 0.1%
Triton X-100) for 10 min, to remove cytoplasmic proteins; next, cells were lysed in
hypertonic buffer (20 mM HEPES pH 8.0, 1 mM EDTA, 400 mM NaCl, 20%
glycerol, 0.1% Triton X-100) for 20 min, to isolate soluble nuclear fraction, and
finally lysed in insoluble buffer (20 mM TRIS pH 8.0, 150 mM NaCl, 1% SDS, 1%
NP-40, 10 mM iodoacetamide) for 50 min to collect insoluble nuclear fraction.
S9.6 immunofluorescence. Next, 8 × 104 MRC-5 cells were plated on round
13 mm glass coverslips followed or not by siRNA transfection. Following 48 h, cells
were treated with 50 μM AMN for 15 h, 50 μM MG132 for 2 h or 25 μM CPT for
10 min. Dimethyl sulfoxide (DMSO) served as a negative control. Next, cells were
washed in ice-cold phosphate-buffered saline (PBS), fixed with methanol : acetone
(1 : 1) solution for 10 min at −20 °C. This was followed by three rounds of PBS
washes and an incubation with 3% filtered bovine serum albumin (BSA) for 30 min
at room temperature. Next, primary antibodies were added for an hour at room
temperature, which was followed by three rounds of PBS washes and secondary
antibodies+DAPI (4′,6-diamidino-2-phenylindole) incubation for an hour. Next,
three PBS washes were carried out and the coverslips fixed on 26 × 76mm
microscope slides using VectaShield mounting medium H-1000 (Vector Labora-
tories, Burlingame, CA). Images were taken under Leica FW4000 Fluorescent
Microscope (Leica Biosystems, Wetzlar, Germany) or Nikon confocal microscope
system A1 (Nikon Instruments, Tokyo, Japan). All the images were processed and
analysed in ImageJ in the same manner. Nucleolar and nuclear masks were gen-
erated for anti-nucleolin images using ImageJ. Nucleolar and nuclear intensities
were corrected for the background noise.
Proximity ligation assay. Duolink™ PLA (Merck, Darmstadt, Germany) kit was
used following manufacturer’s instructions. For negative controls, the protocol was
followed with an omission of one or both primary antibodies. In brief, 6 × 104
MRC-5 cells were plated on round 13 mm glass coverslips on day 1. On day 2, cells
were treated with 50 μM AMN overnight as indicated. On day 3, cells were treated
with 25 μM CPT for 10 min. DMSO was used as a negative control. Subsequently,
cells were washed in ice-cold PBS, fixed with methanol for 5 min at −20 °C, washed
again and incubated in PLA blocking buffer for 60 min at 37 °C. If cells were
transfected with enhanced GFP (eGFP) plasmids, 20 min 4% paraformaldehyde at
room temperature incubation followed by 3 min 0.2% Triton X-100 on ice incu-
bation were used instead of methanol, in order to preserve eGFP signal. After
blocking, cells were incubated for 1 h at room temperature with appropriate pri-
mary antibodies, followed by incubation with PLUS and MINUS PLA probes for
60 min at 37 °C, ligation mix for 30 min at 37 °C and amplification mix for 100 min
at 37 °C. Finally, washed coverslips were fixed on 26 × 76 mm microscope slides
using VectaShield mounting medium H-1000 (Vector Laboratories, Burlingame,
CA). Images were taken under Leica FW4000 Fluorescent Microscope (Leica
Biosystems, Wetzlar, Germany) and processed and analysed in ImageJ in the same
manner.
Clonogenic cell survival assay. Four thousand siRNA-transfected MRC-5 cells
were seeded in a 10 cm dish. Olaparib was added for 24 h, CPT for 1.5 h and
formaldehyde for 3 h. Once the incubation time was over, the media was changed
and cells were left for 7 days to grow. Media was aspirated, plates were air-dried
and cells were fixed with 80% ethanol for 15 min. Then, ethanol was aspirated,
plates were air-dried and cells were stained with 1% Methylene Blue for 1 h. Next,
the plates were washed, air-dried and the colonies were counted. The number of
colonies on untreated plates were treated as 100%. Each biological repeat was an
average of three technical repeats.
5-Ethynyl uridine staining. Protocol for Click-iT® RNA Imaging Kit (Invitrogen,
Carlsbad, CA) was used. Briefly, 8 × 104 cells were seeded on a 13 mm-round glass
coverslip. Next, following cell starvation and AMN treatment, cells were fed FCS-
supplemented media with 5-ethynyl uridine. This was followed by cell fixation,
permeabilization, staining of the 5-ethynyl uridine and mounting. Images were
taken under Leica FW4000 Fluorescent microscope (Leica Biosystems).
GFP pulldown. HEK-293 cells grown in 15 cm dishes were lysed on ice for 30 min
in 200 µl of 20 mM HEPES (pH 7.4), 40 mM (NaCl), 2 mMMgCl2, Triton (1% v/v),
1× Protease Inhibitor, 40 mM NEM and 250 units of Basemucher (Expedeon, San
Diego, CA). Next, cells were spun down at 20,000 × g for 10 min at 4 °C. The
supernatant was aspirated and diluted to 1 ml in 10 mM Tris-HCl pH 7.5, 150 mM
NaCl and 0.5 mM EDTA. Twenty-five microlitres of GFP-Trap®_MA beads
(Chromotek, Planegg-Martinsried, Germany) were washed three times in 10 mM
Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA and added to the supernatants.
The beads and supernatant were left to rotate for 2 h at 4 °C, which was followed by
three washes in 10 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.5 mM EDTA. Next,
bound proteins were eluted by adding 1× SDS loading buffer and boiling at 95 °C
for 10 min with periodic vortexing. Samples were run on a 4–15% precast gel
(BioRad, Hercules, CA) and examined by immunoblotting.
Pulldown under denaturing conditions. HEK-293 cells grown onto 15 cm dishes
were incubated with 25 µM MG132, for 2 h for USP11 depletion experiments or
10 µM MG132 overnight for KEAP1 overexpression, experiments prior to lysis,
which was carried out in 500 µl of 50 mM Tris-HCl (pH 8), 40 mM NaCl, 2 mM
MgCl2, Triton (0.5% v/v), 1× Protease Inhibitor, 20 mM NEM and 250 units of
Fig. 6 KEAP1 opposes USP11 to regulate SETX proteostasis. a Empty vector (EV) and HA-KEAP1 (HA) overexpressing HEK-293 cells were transfected
with Ub-His plasmid, lysed and subjected to nickel pulldown under denaturing conditions to purify ubiquitinated proteins. Samples were fractionated by SDS-
PAGE and analysed by immunoblotting using SETX, HA and His antibodies. * Denotes a nonspecific band (left panel). The band intensities of Ubi-SETX were
normalized to the bait His-Ub and presented as fold increase of SETX ubiquitination in HA-KEAP1 overexpressing cells compared to controls (right panel).
Data are the average ± SD from three biological repeats. p-Values calculated using two-tailed Student’s t-test. b Control (Con Si), USP11-, KEAP1- and double
USP11/KEAP1 (U+ K Si)-depleted HEK-293 cells were transfected with plasmids encoding eGFP-SETX1–667 and Ub-His. Cell lysates were subjected to nickel
pulldown under denaturing conditions to purify ubiquitinated proteins. Samples were fractionated by SDS-PAGE and analysed by immunoblotting using anti-
GFP, USP11, His, KEAP1 and Actin antibodies (left panel). The band intensities of Ubi-eGFP-SETX1–667 were normalized to His-Ub and presented as fold
increase of SETX ubiquitination as compared to controls. Data are the average ± SD from four biological repeats (right panel). p-Values calculated using two-
tailed Student’s t-test. c Lysates from Control (Con siRNA), USP11-, KEAP1- and USP11/KEAP1-depleted cells (USP11/KEAP1 siRNA) were subjected to DNA/
RNA immunoprecipitation (DRIP) protocol using S9.6 antibodies. Quantitative PCR was conducted using primers targeting nucleolar (28S and R7) and
nuclear (ING3, SNRPN-neg,MYADM-neg) loci. SNRPN-neg andMYADM-neg loci are negative controls. Data represent the average ± range from two biological
repeats. d HEK-293 cells expressing eGFP-SETX1–667 were transfected with empty vector-HA (EV) or HA-KEAP1 (HA). Cell lysates were subjected to GFP
pulldown under denaturing conditions to purify eGFP-SETX1–667. Samples were fractionated by SDS-PAGE and analysed by immunoblotting using anti-GFP,
K48 and HA antibodies (left panel). The intensity of K48 signal was normalized to pulled down eGFP-SETX1–667 signal and presented as fold increase
compared to EV. Data are the average ± SD from four biological repeats (right panel). p-Values calculated using two-tailed Student’s t-test.
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Basemucher (Expedeon). Post lysis, 1 volume of equilibration buffer (6 M guani-
dine hydrochloride, 0.05% (v/v) Tween-20, 40 mM imidazole) was added to the
lysates. Thirty microlitres of GFP-Trap®_MA beads (Chromotek, Planegg-Mar-
tinsried, Germany) or His-Pur™ Ni-NTA magnetic beads (ThermoFisher) were
washed twice in a wash buffer (8 M Urea, 0.05% (v/v) Tween-20, 50 mM imidazole,
PBS pH 8.0). Diluted cell lysates were combined with the washed beads and left to
rotate for 1 h at room temperature. Next, the beads were washed three times in the
wash buffer. Then, the beads were boiled in 1× SDS protein loading buffer for
10 min with periodic vortexing. Then, samples were loaded on a 4–15% precast gel
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In vitro deubiquitination of GFP-SETX. Following nickel pull-down assay under
denaturing conditions as described above, nickel beads were not boiled in 1× SDS
buffer but split into two parts. One part was incubated with 2.88 µg/ml BSA,
whereas the other with 2.88 µg/ml recombinant USP11 (Abcam, ab206019) for 4 h
at 30 °C in the deubiquitination buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl,
1 mM EDTA, 1 mM dithiothreitol and 5% glycerol). Next, the beads were washed
and boiled as described above.
Double-thymidine block. Fifty percent confluent HEK-293 cells were supple-
mented with 4 mM thymidine and were left to incubate for 18 h. Next, thymidine-
containing media was aspirated and fresh media was added for 8 h, which was
followed by another incubation with 4 mM thymidine for 18 h.
DUB screen. An ON-TARGET plus siRNA library for human DUBs (G-104705-05,
GE Life Sciences) was employed in a 96-well format. The library contained 99 pools
of 4 siRNAs against each of 99 human DUBs. The library was split between two 96-
well plates for each biological repeat and 4 wells/plate containing control siRNAs
were added. First, 50 µl of transfection mixture containing 0.3 µl DharmaFECT1
(Dharmacon, Lafayette, CO) were added to DUB/control siRNA pools in 96-well
plates. Next, 4750 MRC-5 cells were added in 100 µl of MEM on top of the
transfection mixtures. The plates were left for 48 h prior to a 10 min-long 25 µM
CPT treatment, which was followed by S9.6 immunofluorescence assay. DMSO was
used as a control to CPT treatment. Once DMSO/CPT-containing media was
aspirated, cells were washed three time with ice-cold PBS, fixed with methanol:a-
cetone (1:1) for 10min at −20 °C and incubated with 3% filtered BSA for 30 min at
room temperature. This was followed by S9.6 antibody incubation for an hour at
room temperature. S9.6 was recycled, cells were washed three times with PBS and
secondary antibody+DAPI solution was added for an hour. Then, cells were
washed three times with PBS and stored in 100 µl of PBS in 4 °C. Images of cells
were automatically taken using ImageXpress® Micro XLS Widefield High-Content
Analysis System (Molecular Devices, San Jose, CA). All acquired images were
automatically quantified by Custom Module of MetaXpress® software, which was
designed to count an average number of S9.6 foci per nucleus. The software scored
only large and bright S9.6 foci, which corresponded to nucleolar R-loops. Next, the
S9.6 foci/cell counts were normalized against controls (control siRNA-treated cells).
Detailed screen data for all 99 DUBs can be found in the Supplementary Data 1.
Slot blotting. Extracted genomic DNA (High Pure PCR Template Preparation Kit,
Roche, Basel, Switzerland) was spotted in duplicates on a nitrocellulose membrane,
which was subsequently air-dried, UV-crosslinked (0.12 J/m2) and immunoblotted
using S9.6 and single-stranded DNA (ssDNA) antibodies. For ssDNA immuno-
blotting, one of the membranes was incubated for 10 min in denaturing (1.5 M
NaCl, 0.5 M NaOH) and then 10 min in neutralizing solutions (0.5 M Tris-HCl pH
7.0, 1 M NaOH) prior to UV-crosslinking (0.12 J/m2).
Statistical analysis. Statistical analysis was conducted using Student’s t-test for
pair-wise comparisons. Two-tailed distribution and two-sample unequal variance
settings were chosen. All data are presented as the average values of at least three
biological repeats. Error bars represent SD unless otherwise stated. p < 0.05 was
considered to be statistically significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support this study are available from the corresponding author upon
reasonable request. The raw DUB siRNA screen data generated in this study are provided
in the Supplementary Information (Supplementary Data 1). Source data are provided
with this paper.
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